Loading…
Based on limited metadata with no full letter text available, PT Shimasse Prata Citra received an FDA Warning Letter on January 9, 2018, regarding an unspecified product type classified as "Other." Without access to the complete letter or detailed subject information, the specific nature of the regulatory violations cannot be determined. The issuing FDA office is also not identified in the available metadata, limiting clarity on the regulatory scope of the enforcement action.